FCGRT and infection: FcRn’s ability to confer humoral immunity is based on its capacity to bidirectionally transcytose IgG molecules across the epithelium lining mucosal barriers and preliminary studies have successfully demonstrated that FcRn conferred protective passive humoral immunity against infections at the site of pathogen entry when neutralizing antibodies were administered to the systemic circulation before infection (24, 29, 35).